Breakthrough Study Identifies Brain Biomarkers Linked to Cognitive Issues in Long COVID Patients
New research identifies brain biomarkers associated with persistent cognitive problems in long COVID patients, paving the way for better diagnosis and personalized treatments.
Recent research has uncovered two key brain biomarkers that may explain the persistent cognitive problems experienced by long COVID sufferers. The study, conducted by researchers at Corewell Health, compared inflammation and brain stress responses between long COVID patients and individuals who recovered fully from COVID-19. Findings revealed that patients with ongoing 'brain fog' and cognitive difficulties exhibit lower levels of nerve growth factor—an indicator of the brain's capacity to form new neural connections—and higher levels of interleukin-10, a marker of inflammation.
While traditional neuropsychological tests showed minimal differences, long COVID patients scored significantly lower on verbal fluency tests, indicating challenges in language processing. Additionally, these patients reported lower quality of life, physical health, and emotional well-being.
The study involved 17 confirmed COVID-19 cases: 10 with long COVID and 7 fully recovered individuals. Results showed a correlation between increased brain inflammation markers and cognitive symptoms. The findings suggest that impaired stress response and inflammation in the brain could contribute to long-term cognitive issues.
Experts emphasize that, despite the small sample size, these results could improve early identification and tailored treatment for long COVID patients. They advocate for a multidisciplinary approach, including assessments of inflammatory and neuromarker profiles, as well as supportive therapies like speech therapy, psychotherapy, and targeted medications.
This research helps validate patients' experiences and highlights the need for comprehensive, personalized care strategies to address persistent neurological symptoms post-COVID. Future larger-scale studies are necessary to confirm these biomarkers' roles and develop effective interventions.
Source: https://medicalxpress.com/news/2025-05-scientists-brain-biomarkers-covid-cognitive.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Early Life Factors and Their Role in Developing Multiple Sclerosis
Recent research highlights how childhood infections, stress, maternal age, and physical activity levels can influence the risk of developing multiple sclerosis later in life. Discover how early-life factors may impact MS development and prevention strategies.
New Insights into Rare Skin Disease Mechanisms Open Pathways for Targeted Treatments
Innovative research into the mechanisms of rare skin conditions like Sweet's syndrome reveals potential for targeted therapies that could revolutionize treatment options and reduce side effects. source: https://medicalxpress.com/news/2025-10-mechanisms-rare-skin-disease-treatments.html
Analysis Reveals Lack of Transparency and Penalties for Serious Errors in Rehab Hospitals
A recent analysis uncovers serious safety issues in rehab hospitals, including patient deaths and medication errors, with limited penalties and transparency from federal agencies. Learn about the risks and oversight gaps in this profitable industry.
The Impact of Fans on Older Adults During Dry Heat: A Closer Look
Research highlights that using fans can help older adults stay cooler in humid heat, but may increase heat stress in dry conditions. Learn more about effective cooling strategies for seniors.